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The aim of this study has been to elucidate the effect of the probiotic Enterococcus faecium NCIMB 10415 on epithelial integrity
in intestinal epithelial cells and whether pre- and coincubation with this strain can reproducibly prevent damage induced by
enterotoxigenic (ETEC) and enteropathogenic Escherichia coli (EPEC). Porcine (IPEC-J2) and human (Caco-2) intestinal epithelial
cells were incubated with bacterial strains and epithelial integrity was assessed by measuring transepithelial electrical resistance
(TEER) and mannitol flux rates. E. faecium alone increased TEER of Caco-2 cells without affecting mannitol fluxes whereas the E.
coli strains decreased TEER and concomitantly increasedmannitol flux rates in both cell lines. PreincubationwithE. faecium had no
effect on the TEER decrease induced by E. coli in preliminary experiments. However, in a second set of experiments using a slightly
different protocol, E. faecium ameliorated the TEER decrease induced by ETEC at 4 h in IPEC-J2 and at 2, 4, and 6 h in Caco-2
cells. We conclude that E. faecium positively affected epithelial integrity in monoinfected Caco-2 cells and could ameliorate the
damage on TEER induced by an ETEC strain. Reproducibility of the results is, however, limited when experiments are performed
with living bacteria over longer periods.
1. Introduction
Following the ban of antibiotic growth promoters in farm
animals in the European Union in 2006, the search for
alternative growth and health promoters has been intensified.
Among such promoters, probiotics seem to be a suitable
feed additive promoting health and performance parameters
of piglets [1–3]. However, research with regard to their
application in farm animals is still fragmentary and our
present knowledge concerning the underlyingmechanisms of
the effects of probiotics is limited.
Enterococcus faeciumNCIMB 10415 (E. faecium) is used as
a probiotic supplement in farm animals. It has shown positive
effects on diarrhoea incidence [4, 5] and daily weight gain [5]
in pigs. Furthermore, effects on immunological parameters
in the gastrointestinal tract [6–8] and effects on transport
properties in the pig jejunum [9] have been observed.
The mechanisms of these effects are still not well under-
stood. For a better understanding of the interaction between
intestinal cells and probiotics, cell models can be used, as
done with human probiotic preparations [10–12].
Therefore, we have examined the effects of E. faecium
in a model of porcine intestinal epithelial cells, namely,
in IPEC-J2 cells isolated from the jejunum of a newborn
piglet [13, 14]. Their usefulness as a model for studies of
microbial pathogenesis in pigs has previously been assessed
[15]. Up to now, these cells have been used in probiotic studies
with different strains, including assessments of the adhesion
capability of various probiotic strains such as Lactobacillus
plantarum, Enterococcus faecium EF2019, and Saccharomyces
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cerevisiae [16–19] and of the capability of probiotics to inhibit
inflammatory responses [18, 20] or their antiviral activity [21].
In the present study, we have focused on the barrier
function of the epithelial cells. We have compared a human
cell line, namely, Caco-2, an established in vitro model of
small intestinal mucosa, and a porcine cell culture model,
namely, IPEC-J2, with regard to their response to incubation
with probiotic E. faecium and pathogenic Escherichia coli
strains. We have addressed the question as to whether E.
faecium and two selected pathogenic E. coli strains affect
the barrier function of porcine intestinal epithelial cells.
Furthermore, we assumed that the effects of pathogenic
strains can be modified by E. faecium. In the performed
experiments, intestinal epithelial cells were incubated long-
term with live bacteria.
2. Materials and Methods
2.1. Cells and Culture Conditions. The porcine intestinal
epithelial cell line (IPEC-J2) was established from the
jejunum of a newborn piglet [13, 14] and kindly pro-
vided by Professor Anthony Blikslager (North Carolina State
University, USA). The IPEC-J2 cells were maintained in
Dulbecco’s modified Eagle medium (DMEM)/Ham’s F-12
medium (1 : 1), supplemented with 5% fetal bovine serum
(FBS, Biochrom, Berlin, Germany), 2.5mmol/L L-glutamine
(Biochrom, Berlin, Germany), insulin (5𝜇g/mL), transferrin
(5 𝜇g/mL), selenium (5 ng/mL) (ITS, Sigma-Aldrich Chemie
GmbH, Taufkirchen, Germany), epidermal growth factor
(EGF, 5 ng/mL, Biochrom, Berlin, Germany), and penicillin-
streptomycin (Sigma-Aldrich Chemie GmbH, Taufkirchen,
Germany). IPEC-J2 cells were passaged by trypsinization
(0.15 g/L porcine trypsin, 0.06 g/L EDTA, Sigma-Aldrich
Chemie GmbH, Taufkirchen, Germany). Cells were used
consistently within 14 days from the seeding of passages 69–
79.
Human epithelial intestinal cells from colorectal adeno-
carcinoma, Caco-2 (ATCC Catalog number HTB-37, ATCC,
Manassas, USA) were maintained in Eagle’s minimum essen-
tial medium with Earle’s BSS and 2mmol/L L-glutamine
(EMEM, LGC Standards GmbH, Wesel, Germany) modified
byATCC to contain 1.0mmol/L sodiumpyruvate, 0.1mmol/L
nonessential amino acids, 1.5 g/L sodium bicarbonate, and
supplemented with 20% FBS and penicillin-streptomycin.
Cells were studied between passages 33 and 46 and subcul-
tured every 4-5 days, after trypsin treatment (2.5 g/L porcine
trypsin and 0.2 g/L EDTA, Sigma-Aldrich Chemie GmbH,
Taufkirchen, Germany).
Both cell lines were grown at 37∘C in a humidified
atmosphere of 5% CO
2
. Cell cultures were routinely tested
and found to be free of mycoplasma contamination. On the
day prior to experiments, the cells were fed with serum- and
antibiotic-free medium.
2.2. Transepithelial Electrical Resistance (TEER) Measure-
ments. For TEER, mannitol, and pHmeasurements, the cells
were seeded on clear polyester membrane cell culture inserts
(Snapwell, 12mm diameter, 1.12 cm2 area, 0.4 𝜇m pore size;
Corning B.V., Schiphol-Rijk, Netherlands). The membranes
were coated with rat tail collagen type I (Serva Electrophore-
sis GmbH, Heidelberg, Germany) for IPEC-J2 cells. Cells
were seeded at a density of 105 cells/1.12 cm2 andwere allowed
to differentiate for 14 days (IPEC-J2) or 21 days (Caco-2).
TEER measurements were performed by using a Millicell-
ERS (Electrical Resistance System; Millipore GmbH, Schwal-
bach, Germany). TEER values were corrected for the resis-
tance of blank filters and for the membrane area. Measure-
ments were started after the cell monolayers had reached
confluency.
2.3. Bacterial Strains. Cells were incubated with bacteria
from the (1) probiotic strain Enterococcus faecium NCIMB
10415 (cultivated from Cylactin; Cerbios-Pharma, Barbengo,
Switzerland, and provided by David Taras, Institute of Ani-
mal Nutrition, Berlin, Germany), (2) enterotoxigenic E. coli
IMT4818 (ETEC, isolated from a two week-old piglet with
enteritis, O149:K91:K88 (F4) and found to be positive for
the presence of virulence genes est-1a, est-2 (genes coding
for heat stable enterotoxins I and II), and elt-1a/b (gene
coding for heat labile enterotoxin I) by polymerase chain
reaction (PCR)), or (3) human enteropathogenic E. coli
E2348/69 (EPEC, serotype O127:H6 and positive for eae (E.
coli attaching-effacing) gene).
E. faecium NCIMB 10415 was grown in brain-heart
infusion (BHI) broth (OXOID GmbH,Wesel, Germany) and
the ETEC and EPEC strains were grown in LB medium
containing 10 g/L tryptone, 5 g/L yeast extract, and 10 g/L
NaCl, at a pH of 7.0. Tryptone and the yeast extract were from
OXOID.
After overnight incubation at 37∘C, subcultures of bacte-
ria grown for ∼3 h until midlog phase were centrifuged and
washed twice in phosphate-buffered saline (PBS, Biochrom,
Berlin, Germany). Bacterial cells were then resuspended in
antibiotic- and serum-free IPEC-J2 or Caco-2 cell culture
medium at a concentration of ∼108 colony-forming units
(CFU)/mL. From this solution, aliquots were added to the
apical compartment of the cell culture inserts, which contains
0.5mL media, to reach the concentrations indicated below.
Bacterial concentration was determined by measuring
the optical density and confirmed by serial dilution followed
by determining viable counts on agar plates (Columbia
blood agar, PC agar for all strains, Endo agar for E. coli
strains, and Citrate Azide Tween Carbonate Agar for E.
faecium) in preliminary experiments. Cells were infectedwith
106, 107 and, for the E. faecium strain, also with 5 × 106
bacteria per cell culture insert (1.12 cm2), corresponding to
a multiplicity of infection (MOI) of 10, 50, and 100 bacteria,
respectively, per seeded cell. When the cells were infected
with E. faecium and either the ETEC or the EPEC together,
cells were preincubated with E. faecium for 3 h in the first set
of experiments and for 2 h in the second set of experiments
and, after that, the pathogenic E. coli strains were added. The
cells were in contactwith theE. coli for the sameduration as in
the monoincubation monolayers with either ETEC or EPEC.
This setup will be called “coincubation” in the following and
the incubation time will be given as the time that the cells
were incubated with the pathogenic E. coli strains.
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2.4. Measurements of 3H-Mannitol Fluxes. Flux rates of
mannitol were measured by using D-[1-3H]-mannitol
(PerkinElmer Life Sciences, Rodgau-Ju¨gesheim, Germany).
The isotope (0.3 𝜇Ci) was added to the apical side of the cell
monolayers, and the cells were incubated for 30min to allow
equilibration of the isotope. Fluxes were calculated from the
rate of appearance of tracer on the serosal side of the cell
monolayer within 60min (three fluxes of 20min). D-[1-3H]-
Mannitol was assayed by using a well-type crystal 𝛽-counter
(LKBWallace-PerkinElmer, U¨berlingen, Germany).
2.5. pH Measurements. The pH of cell culture media at the
apical side of the cellmonolayers wasmeasuredwith an InLab
Surface electrode (Mettler Toledo Online GmbH, Na¨nikon,
Switzerland) connected to a pH meter (inoLab pH 720,
Wissenschaftlich-Technische Werksta¨tten GmbH, Weilheim,
Germany).
2.6. Statistical Analysis. Statistical evaluations were carried
out by means of the PASW Statistics program for Windows,
version 18 (Jandel, Chicago, IL, USA). Graphs were plotted
with Excel 2010. Unless otherwise stated, results are given
as mean ± standard error of the mean. The number of
cell monolayers that entered the statistical evaluation is
indicated in the relevant tables and figure legends. Results
were considered to be significant at 𝑃 ≤ 0.05.
To assess the effect of the various numbers of bacteria
(“dose”) on TEER, a one-way analysis of variance with the
fixed factor “dose” (0, 106, 5 × 106, 107/1.12 cm2 or 0, 106,
107/1.12 cm2), was conducted per time point (h) with a post
hoc Scheffe test. For effects of incubation with E. faecium on
TEER, a one-way analysis of variance with the fixed factor
“treatment” (control, E. faecium) was conducted per time
point. For effects of bacterial incubation and preincubation
with E. faecium on TEER, a one-way analysis of variance with
the fixed factor “treatment” (control:E. faecium, ETEC, andE.
faecium + ETEC; control: E. faecium, EPEC, and E. faecium +
EPEC) was conducted per time point with a post hoc Scheffe
or LSD (least significant difference) test.
3. Results
3.1. Determination of the Incubation Conditions. TEER
reached values of∼5000Ohm× cm2 in confluent IPEC-J2 cell
monolayers after 14 days in culture and ∼550Ohm × cm2 in
Caco-2 cells after 21 days. Next, we optimized the incubation
conditions for the infection model by testing various dosages
of the E. faecium (106, 5 × 106, and 107 CFU/cell culture
inserts) and the two pathogenic E. coli strains (106 and
107 CFU/cell culture inserts).
Changes of TEER were measured over 12 h in IPEC-J2
cells after mucosal addition of bacterial strains (Figure 1).
When the cell monolayers were exposed to increasing doses
of E. faecium, the TEER values showed no significant dif-
ferences (Figure 1(a)). In contrast, in IPEC-J2 cell monolay-
ers incubated with the ETEC strain, the highest infection
dose induced a significant decrease in TEER beginning at
4 h and reaching values of ∼20% of the initial value after
6 h (Figure 1(b)). When the IPEC-J2 cells were incubated
with EPEC, the TEER was significantly decreased compared
with the control from 6 or 8 h onwards at the highest and the
lower infection doses, respectively (Figure 1(c)).
In Caco-2 cells, the highest dose of E. faecium induced a
decrease in TEER after 24 h (Figure 2(a)).
When the Caco-2 cells were incubated with ETEC, the
TEER decreased in a concentration-dependentmanner start-
ing already at 2 h (Figure 2(b)). In contrast, when infected
with EPEC, the TEER did not significantly differ from the
control group until 8 h (Figure 2(c)). Thereafter, a decrease
was observed at the highest infection dose and, after 12 h, also
at the lower infection dose.
In some of the experiments, mannitol flux rates were
measured, as amarker of paracellular permeability, in parallel
to the measurement of TEER (see Tables 1 and 2). The
mannitol flux rates reflected the changes in TEER.
3.2. Effects of the Probiotic E. faecium on TEER. We chose an
E. faecium concentration of 106 bacteria/1.12 cm2 for all fur-
ther experiments and observed an enhancing effect on TEER
over 12 h in Caco-2 cell monolayers, which was significant
from 6 h to 10 h (Figure 3(b)). No such effect was observed
in IPEC-J2 cell monolayers. Instead, the TEER of IPEC-J2 cell
monolayers incubatedwith E. faecium significantly decreased
from 8 h onwards in this experimental series (Figure 3(a)).
3.3. Effects of Coincubation with E. faecium on Pathogenic
Challenge in a First Series of Experiments. As we were
interested in whether the effects of a pathogenic challenge
by the E. coli strains could be prevented by the probiotic E.
faecium, we preincubated the epithelial cells for 3 h with E.
faecium, after which time the pathogenic E. coli strains were
added. In parallel, cell monolayers were monoinfected with
the respective strains, the incubation lasted for 12 h (IPEC-J2)
and 24 h (Caco-2), respectively. In both cell lines, E. faecium
did not reproducibly delay the decrease in TEER induced by
ETEC and EPEC (data not shown).
The pH in cell culture inserts was measured at the
apical side of the cell monolayer. For IPEC-J2 cells, the pH
values decreased with time and were below 6.5 after 10 h of
incubation with EPEC and the E. faecium coincubation with
ETEC and EPEC. The pH of Caco-2 cell media decreased
below 7 after 10 h for theE. coli strains and their coincubations
(data not shown).
3.4. Effects of Coincubation with E. faecium on Pathogenic
Challenge in a Second Set of Experiments. Based on the
results of the first set of experiments, we conducted a further
set of experiments with shorter incubation times. In these
experiments, only the effects of ETEC were tested, taking
care to exactly match the duration of incubation of cells with
the pathogenic E. coli in both monoinfected and coincubated
cells. In these experiments, the coincubation with E. faecium
could ameliorate the decrease in TEER induced by ETEC
at 4 h in IPEC-J2 and at 2, 4, and 6 h in Caco-2 cells (see
Figure 4).
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Table 1: Mannitol flux rates and their corresponding TEER values in IPEC-J2 cell monolayers incubated with various bacterial strains.
Control Ecf ETEC EPEC Sampling time
TEER (Ohm∗cm2) 4760 ± 1283 4744 ± 1187 3021 ± 2341 4590 ± 1263
4 hMannitol flux (nmol∗cm−2∗h−1) 4.4 ± 3.2 3.9 ± 3.7 6.5 ± 5.4 15.2 ± 13.8
𝑛 TEER|𝑛Mannitol 14|6 15|7 14|9 12|6
TEER (Ohm∗cm2) 3518 ± 1397a 3692 ± 1177a 2690 ± 2428ab 1115 ± 1018b 8 h
Mannitol flux (nmol∗cm−2∗h−1) 2.1 ± 2.6a 3.4 ± 2.0a 11 ± 12.2ab 26.9 ± 25.1b 8 h
𝑛 TEER|𝑛Mannitol 13|8 14|7 13|4 11|6
Bacterial strains: IPEC-J2 cells were incubated with E. faecium (Ecf), ETEC, or EPEC for 4 h and 8 h (mean ± standard deviation, variance analysis, post hoc














































































































Figure 1: TEER values (% of initial value 𝑡 = 0 h) of IPEC-J2 cells during 12 h of incubation with various doses of (a) E. faecium, (b) ETEC,
or (c) EPEC (MOI = multiplicity of infection per seeded cell) on Snapwell collagenized polyester membranes (mean ± SEM), 𝑛 = 6–11 cell
culture inserts. Different letters indicate significant differences between treatment groups per time point (𝑃 ≤ 0.05).
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Table 2: Mannitol flux rates and their corresponding TEER values in Caco-2 cell monolayers incubated with various bacterial strains.
Control Ecf ETEC EPEC Sampling time
TEER (Ohm∗cm2) 327 ± 68a 359 ± 89a 35 ± 38b 135 ± 116b
10 hMannitol flux (nmol∗cm−2∗h−1) 11 ± 3.9a 11.4 ± 7.2a 86.7 ± 26.6b 108 ± 25.9b
𝑛 TEER|𝑛Mannitol 8|5 9|6 9|6 7|5
Bacterial strains: Caco-2 cells were incubated with E. faecium (Ecf), ETEC, or EPEC for 10 h (mean ± standard deviation, variance analysis, post hoc Scheffe

































































































































Figure 2: TEER values (% of initial value 𝑡 = 0 h) of Caco-2 cells during 24 h after treatment with various doses of (a) E. faecium (b) ETEC,
or (c) EPEC (MOI = multiplicity of infection per seeded cell) on Snapwell collagenized polyester membranes (mean ± SEM), 𝑛 = 5–9 cell





























































Figure 3: TEER values (% of initial value 𝑡 = 0 h) of IPEC-J2 cells (a) and Caco-2 (b) cells during 12 h of incubation with control medium or
E. faecium (106 CFU per cell culture insert) (mean ± SEM), IPEC-J2: 𝑛 = 22–39 cell culture inserts; Caco-2: 𝑛 = 16–36 cell culture inserts. The
























































































E. faecium + ETEC
ETEC
(b)
Figure 4: TEER values of IPEC-J2 (a) and Caco-2 (b) cells during 8 h of treatment with various bacterial strains: control without bacteria,
E. faecium, ETEC, E. faecium + ETEC, incubation time adjusted to the addition of the E. coli strain (mean ± SEM), and 𝑛 = 11-12 cell culture
inserts per time point. Different letters indicate significant differences between treatment groups per time point (𝑃 ≤ 0.05).
4. Discussion
Probiotic feed supplementation is an alternative for the use
of antibiotic growth promoters in farm animals that is now
prohibited in the EU. E. faecium NCIMB 10415 is accredited
as a feed supplement for piglets and has positive effects
on health incidence and performance parameters [4, 5],
which cannot be satisfactorily explained on the basis of our
present knowledge. The possible improvement or protection
of the intestinal barrier function has been discussed as one
possible mechanism of probiotic action [11, 12]. The present
study has been undertaken to determine the validity of
these arguments. The effects of E. faecium and two selected
pathogenic bacterial E. coli strains on TEER of IPEC-J2 (pig)
and Caco-2 (human) cell monolayers have been investigated.
Of particular interest was the potential beneficial effect of
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E. faecium on the barrier integrity of the IPEC-J2 cell line,
because studies regarding the complete or partial abrogation
of the impairing effects of pathogenic E. coli by probiotics
have mostly been conducted with human cell lines and
probiotics used in human nutrition [22–26].
4.1. Experimental Model. We used live bacteria in our study,
because various cell structures or secreted factors, such as
bacterial DNA, secreted substances, and cell wall compo-
nents,might be responsible for any effects induced.The infec-
tionmodel proved difficult to handle because the time course
of the change in TEER after addition of bacteria differed
between experiments conducted on different days. The latter
occurred despite due care to have a highly standardized pro-
cedure and may point to the fact that even minor differences
in cell passages and batches of bacterial culturemay have huge
impacts on the experimental outcome. An overall statistical
evaluation of the results ofmultiple independent experiments
was therefore difficult. In addition, we used live bacteria over
a long period of time, during which theymultiplied in the cell
culture wells. This had effects on the pH of the cell culture
media which declined and hence the data from later time
points could have been influenced by the change in pH. We
therefore reduced the duration of the incubation time when
we tested the probiotic effect on changes induced by ETEC in
a second set of coculture experiments.
4.2. Effects of E. faecium Per Se on TEER. TEER is measured
as a parameter to assess the variation of the integrity and
permeability of the epithelial barrier [27–29] and is given by
the cellular resistance, 𝑅
𝑐
, and the shunt resistance, 𝑅
𝑠
, which






The E. faecium strain had either no effect on TEER or
resulted in a decrease in the TEER in IPEC-J2 cells from
8 h of incubation onwards. In Caco-2 cells, the TEER was
increased by E. faecium at a concentration of 106/1.12 cm2.
The latter findings are in general agreement with results from
other probiotics (Bifidobacterium infantis, E. coli Nissle 1917,
Lactobacillus acidophilus, Streptococcus thermophilus, VSL#3,
L. rhamnosus, and Saccharomyces boulardii) and cell lines
(T84, HT29/cl.19A, and Caco-2) [30–34]. The application
of probiotics alone, without a pathophysiological challenge,
in in vitro studies with intestinal epithelia has either an
enhancing effect [30–32] or no effect on TEER [26, 33, 34],
with the effect being dose- and time-dependent [31, 35, 36].
4.3. Effect of E. faecium during Pathogenic Challenge. We
furthermore hypothesised that E. faecium could prevent
decreases in TEER in a pathophysiological challenge. There-
fore, we chose two pathogenic E. coli strains, one isolated
from pig and the other from human, that decreased TEER in
a time- and dose-dependent manner specific to the bacteria
and their mode of action and cell lines used. This decreasing
effect on TEER confirmed results of similar experiments
with different cell lines, bacteria, or infection doses. A TEER
decrease by E. coli O149K91 (F4 (K88ac) (ETEC) with heat
labile (LT+) and heat stable (STb+) enterotoxins) in IPEC-
J2 cells has also been observed by Geens and Niewold [37]
at MOI of 10 : 1 (to 2% of the initial value after 4 h). Similar
results have been reported for Caco-2 cells in the study of
Roselli et al. [38] in which the TEER fell to about 50% after 3 h
(5× 107 bacteria/1.12 cm2).This disruption of barrier function
by ETEC might in part be attributable to lipopolysaccharide
or bacterial metabolites [37].
In Caco-2 cells incubated with EPEC (EPEC O127:H6,
E2348/69), the TEER fell below 50% at 4 h in the study of
Anderson et al. [39]. The decrease in TEER after incubation
with EPEC is a result of the disruption of tight junction
integrity by two type III secreted effector molecules and a
bacterial surface protein (Dean and Kenny, 2004, and Hecht,
2001). It is also possible that induction of enterocyte apoptosis
contributes partly to the TEER increase after EPEC exposure.
However, it has been previously shown that changes in
epithelial resistance can occur independent of the induction
of epithelial cell apoptosis, at least, in Caco-2 cells [40].
The effects on TEER were reflected by the changes in the
mannitol flux rates as a marker for paracellular permeability.
The decrease in TEER and concomitant increase in mannitol
flux in response to the pathogenic E. coli strains commonly
point to an opening of the paracellular permeation pathway
and could be due to a change or delocalization of TJ or
cytoskeletal proteins. Probiotic bacteria such as L. plantarum,
L. acidophilus, or L. rhamnosus have previously been shown
to prevent these effects of E. coli on barrier function in studies
with Caco-2 or T84 cells [33, 39]. For example, L. sobrius
DSM 16698 protected IPEC-1 cells (derived from porcine
jejunum and ileum) from the disruption of TJ structure by
inhibiting the delocalization of ZO-1, the reduction in the
amount of occludin, the rearrangement of F-actin, and the
dephosphorylation of occludin caused by an enterotoxigenic
E. coli strain [41]. This has also been shown in animal
studies in vivo; for example, one week of pretreatment with L.
plantarum in the drinkingwater abolished theE. coli-induced
increase ofmannitol passage in the small intestine of rats [42].
TheETECandEPEC strains have been used in the current
study as a pathogenic challenge to examine whether the
decrease observed in TEER can be prevented or reduced by
the probioticE. faecium.The cell lineswere preincubatedwith
the probiotic before the application of ETEC or EPEC. This
design was chosen based on the observation that in most
of the studies in which pathogens or other damaging agents
have been employed, only pretreatmentwith the probiotic has
produced the designated effect [22, 33]. Preincubationwith E.
faecium did not diminish the effects of the pathogenic strains
ETEC and EPEC in preliminary experiments but diminished
the TEER decrease induced by ETEC in the second set of
experiments.
As discussed above, the decrease in TEER induced by
pathogenic E. coli strains was different on several days and in
the preliminary challenge experiments the decrease in TEER
started later. Furthermore, we used different preincubation
times (3 h and 2 h) with the probiotic strain before the
pathogenic strain was added.
Although the main effects towards incubation with bac-
teria were rather similar, some differences between the two
cell lines could be observed. When the cells were incubated
with ETEC strain, Caco-2 cells reacted earlier with a decrease
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in TEER and at lower bacterial concentrations (MOI 10)
than IPEC-J2 cells (Figures 1, 2, and 4). Oppositely, the
decrease in TEER induced by EPEC occurred generally later
than that observed after addition of ETEC, with IPEC-J2
cells reacting slightly earlier. The ETEC strain was isolated
from a piglet and the EPEC strain is a human strain and it
might be speculated that the IPEC-J2 cells might be more
adapted to the porcine pathogen. Besides species differences,
the differences between the cells might also be due to their
origin (tumorous or nontumouros tissues) and might also be
influenced by the cell-specificmedia (e.g., regarding buffering
capacity). As stated by Geens and Niewold [43] IPEC-J2
may represent a better model of normal intestinal epithelial
cells than transformed cell lines because they maintain their
differentiated characteristics and exhibit strong similarities to
primary intestinal epithelial cells.
5. Conclusions
The increasing application of probiotics in animal nutrition
requires an investigation of the underlying mechanisms of
their health-promoting effects. E. faecium NCIMB 10415,
which has been accredited for piglet nutrition, induces an
increase in TEER in human epithelial cellmonolayers, but not
in the porcine intestinal cell model. Pre- and coincubation
with E. faecium could ameliorate the decrease in TEER
induced by enterotoxigenic E. coli. However, the effects of
the probiotic strain in pathogenic challenges differed in two
experimental setups and for further experiments shorter
incubation times should be used.
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